Enliven Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enliven Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $16M | 307k | 50.75 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management